<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Biomarkers | The Miller Lab</title>
    <link>/tags/biomarkers/</link>
      <atom:link href="/tags/biomarkers/index.xml" rel="self" type="application/rss+xml" />
    <description>Biomarkers</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><lastBuildDate>Fri, 06 Dec 2019 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/img/MLab_logo_5.png</url>
      <title>Biomarkers</title>
      <link>/tags/biomarkers/</link>
    </image>
    
    <item>
      <title>Cutaneous Oncology Research Fellow</title>
      <link>/post/cutaneous-oncology-research-fellow/</link>
      <pubDate>Fri, 06 Dec 2019 00:00:00 +0000</pubDate>
      <guid>/post/cutaneous-oncology-research-fellow/</guid>
      <description>&lt;p&gt;The Massachusetts General Hospital Cancer Center and the Department of Dermatology are offering a 1-2 year research fellowship in cutaneous oncology. This position will provide a unique experience in cutaneous oncology and will include roles in clinical investigation and translational research.&lt;/p&gt;

&lt;p&gt;Please see the attached PDF for more information.&lt;/p&gt;

&lt;p&gt;&lt;a href=&#34;./CORF-post.pdf&#34;&gt;Cutaneous Oncology Research Fellow Posting&lt;/a&gt;&lt;/p&gt;

&lt;p&gt;&lt;strong&gt;Current Fellows&lt;/strong&gt;&lt;br /&gt;
- &lt;a href=&#34;https://www.themillerlab.io/authors/fellows/&#34; target=&#34;_blank&#34;&gt;Sophia Shalhout, PhD&lt;/a&gt;
&lt;img src=&#34;/img/SZS.png&#34; alt=&#34;png&#34; /&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Biomarkers of Response and Resistance to Cancer Therapy</title>
      <link>/project/biomarkers/</link>
      <pubDate>Wed, 27 Nov 2019 00:00:00 +0000</pubDate>
      <guid>/project/biomarkers/</guid>
      <description>

&lt;h1 id=&#34;overview&#34;&gt;Overview&lt;/h1&gt;

&lt;p&gt;We are investigating why patients respond - or fail to respond - to cancer therapies&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
